|
EP2061767B1
(de)
|
2006-08-08 |
2014-12-17 |
Sanofi |
Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
|
|
EP2002835A1
(en)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2000176A1
(en)
|
2007-06-04 |
2008-12-10 |
GenKyo Tex |
Tetrahydroindole derivatives as NADPH Oxidase inhibitors
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
TW200924762A
(en)
|
2007-11-02 |
2009-06-16 |
Vertex Pharma |
Kinase inhibitors
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
EP2166010A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2165707A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2166009A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as nadph oxidase inhibitors
|
|
US8957219B2
(en)
|
2008-10-17 |
2015-02-17 |
Shionogi & Co., Ltd. |
Acetic acid amide derivative having inhibitory activity on endothelial lipase
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
KR20120060207A
(ko)
|
2009-08-26 |
2012-06-11 |
사노피 |
신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
|
|
EP2305679A1
(en)
|
2009-09-28 |
2011-04-06 |
GenKyoTex SA |
Pyrazoline dione derivatives as nadph oxidase inhibitors
|
|
KR20120123325A
(ko)
|
2009-12-15 |
2012-11-08 |
시오노기세야쿠 가부시키가이샤 |
혈관 내피 리파아제 저해 활성을 갖는 옥사디아졸 유도체
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
GB2497476B
(en)
*
|
2010-09-06 |
2018-01-10 |
Guangzhou Inst Biomed & Health |
Amide Compounds
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2760828B1
(en)
|
2011-09-27 |
2015-10-21 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
US9493412B2
(en)
|
2011-09-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
EP2760829B1
(en)
|
2011-09-27 |
2016-05-18 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
WO2013048930A1
(en)
|
2011-09-30 |
2013-04-04 |
Bristol-Myers Squibb Company |
Pyridinedione carboxamide inhibitors of endothelial lipase
|
|
EP2760840B1
(en)
|
2011-09-30 |
2015-08-12 |
Bristol-Myers Squibb Company |
Quinolinone carboxamide inhibitors of endothelial lipase
|
|
WO2013049104A1
(en)
|
2011-09-30 |
2013-04-04 |
Bristol-Myers Squibb Company |
Pyridinedione carboxamide inhibitors of endothelial lipase
|
|
EP2844643B1
(en)
|
2012-04-03 |
2016-11-30 |
Bristol-Myers Squibb Company |
Pyrimidinedione carboxamide inhibitors of endothelial lipase
|
|
US9394260B2
(en)
|
2012-04-03 |
2016-07-19 |
Bristol-Myers Squibb Company |
Pyrimidinone carboxamide inhibitors of endothelial lipase
|
|
AR092854A1
(es)
|
2012-07-09 |
2015-05-06 |
Bristol Myers Squibb Co |
Benzotiazoles que contienen sulfonilo como inhibidores de la lipasa endotelial
|
|
US9139578B2
(en)
|
2012-07-09 |
2015-09-22 |
Bristol-Myers Squibb Company |
Amide or urea containing benzothiazole inhibitors of endothelial lipase
|
|
WO2014015088A1
(en)
|
2012-07-19 |
2014-01-23 |
Bristol-Myers Squibb Company |
Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase
|
|
WO2014042939A1
(en)
|
2012-09-11 |
2014-03-20 |
Bristol-Myers Squibb Company |
Ketone linked benzothiazole inhibitors of endothelial lipase
|
|
US10173991B2
(en)
|
2014-01-07 |
2019-01-08 |
Bristol-Myers Squibb Company |
Sulfone amide linked benzothiazole inhibitors of endothelial lipase
|
|
US9879016B2
(en)
|
2015-04-17 |
2018-01-30 |
Abbvie Inc. |
Indazolones as modulators of TNF signaling
|
|
US20160304496A1
(en)
|
2015-04-17 |
2016-10-20 |
Abbvie Inc. |
Indazolones as modulators of tnf signaling
|
|
AR104291A1
(es)
|
2015-04-17 |
2017-07-12 |
Abbvie Inc |
Moduladores tricíclicos de la señalización por tnf
|
|
US10597370B2
(en)
|
2016-06-06 |
2020-03-24 |
Bristol-Myers Squibb Company |
2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors
|
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
|
CN110526898A
(zh)
*
|
2018-05-25 |
2019-12-03 |
北京诺诚健华医药科技有限公司 |
3-吲唑啉酮类化合物、其制备方法及其在医药学上的应用
|
|
AU2019318209B2
(en)
|
2018-08-10 |
2025-09-25 |
Diapin Therapeutics, Llc |
Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
|